• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

水脂比和胆碱浓度在良恶性乳腺病变及正常乳腺实质中的诊断价值:体内(1)H MRS 研究。

Diagnostic usefulness of water-to-fat ratio and choline concentration in malignant and benign breast lesions and normal breast parenchyma: an in vivo (1) H MRS study.

机构信息

Departments of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

出版信息

J Magn Reson Imaging. 2011 Apr;33(4):855-63. doi: 10.1002/jmri.22493.

DOI:10.1002/jmri.22493
PMID:21448950
Abstract

PURPOSE

To compare total choline concentrations ([Cho]) and water-to-fat (W/F) ratios of subtypes of malignant lesions, benign lesions, and normal breast parenchyma and determine their usefulness in breast cancer diagnosis. Reference standard was histology.

MATERIALS AND METHODS

In this HIPPA compliant study, proton MRS was performed on 93 patients with suspicious lesions (>1 cm) who underwent MRI-guided interventional procedures, and on 27 prospectively accrued women enrolled for screening MRI. (W/F) and [Cho] values were calculated using MRS data.

RESULTS

Among 88 MRS-evaluable histologically-confirmed lesions, 40 invasive ductal carcinoma (IDC); 10 invasive lobular carcinoma (ILC); 4 ductal carcinoma in situ (DCIS); 3 invasive mammary carcinoma (IMC); 31 benign. No significant difference observed in (W/F) between benign lesions and normal breast tissue. The area under curve (AUC) of receiver operating characteristic (ROC) curves for discriminating the malignant group from the benign group were 0.97, 0.72, and 0.99 using [Cho], (W/F) and their combination as biomarkers, respectively. (W/F) performs significantly (P < 0.0001;AUC = 0.96) better than [Cho] (AUC = 0.52) in differentiating IDC and ILC lesions.

CONCLUSION

Although [Cho] and (W/F) are good biomarkers for differentiating malignancy, [Cho] is a better marker. Combining both can further improve diagnostic accuracy. IDC and ILC lesions have similar [Cho] levels but are discriminated using (W/F) values.

摘要

目的

比较恶性病变、良性病变和正常乳腺实质各亚型的总胆碱浓度([Cho])和水脂比(W/F),并探讨其在乳腺癌诊断中的应用价值。以组织学为参考标准。

材料与方法

本 HIPAA 合规研究纳入 93 例行 MRI 引导下介入活检的可疑病灶(>1cm)患者和 27 例行筛查 MRI 的前瞻性入组女性患者,对其进行质子 MRS 检查。使用 MRS 数据计算 W/F 和 [Cho] 值。

结果

在 88 例可进行 MRS 评估且经组织学证实的病变中,包括 40 例浸润性导管癌(IDC)、10 例浸润性小叶癌(ILC)、4 例导管原位癌(DCIS)、3 例乳腺浸润性癌(IMC)和 31 例良性病变。良性病变与正常乳腺组织的 W/F 无显著差异。使用 [Cho]、W/F 及其组合作为生物标志物鉴别良恶性病变的受试者工作特征曲线(ROC)下面积(AUC)分别为 0.97、0.72 和 0.99。W/F(AUC=0.96)在鉴别 IDC 和 ILC 病变方面显著优于 [Cho](AUC=0.52,P<0.0001)。

结论

虽然 [Cho] 和 W/F 是鉴别良恶性的良好生物标志物,但 [Cho] 是更好的标志物。两者结合可进一步提高诊断准确性。IDC 和 ILC 病变的 [Cho] 水平相似,但可通过 W/F 值进行鉴别。

相似文献

1
Diagnostic usefulness of water-to-fat ratio and choline concentration in malignant and benign breast lesions and normal breast parenchyma: an in vivo (1) H MRS study.水脂比和胆碱浓度在良恶性乳腺病变及正常乳腺实质中的诊断价值:体内(1)H MRS 研究。
J Magn Reson Imaging. 2011 Apr;33(4):855-63. doi: 10.1002/jmri.22493.
2
Combined DCE-MRI and single-voxel 2D MRS for differentiation between benign and malignant breast lesions.联合 DCE-MRI 和单体素 2D MRS 鉴别乳腺良恶性病变。
NMR Biomed. 2010 Oct;23(8):922-30. doi: 10.1002/nbm.1511.
3
Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.3T氢质子磁共振波谱在骨与软组织肿瘤中的初步研究
Chin Med J (Engl). 2009 Jan 5;122(1):39-43.
4
In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.使用3.0-T磁共振成像扫描仪对大的局灶性肝病变进行体内质子磁共振波谱分析以及肝细胞癌经动脉化疗栓塞前后的代谢物变化
J Magn Reson Imaging. 2004 May;19(5):598-604. doi: 10.1002/jmri.20046.
5
Determination of choline concentration in breast lesions: quantitative multivoxel proton MR spectroscopy as a promising noninvasive assessment tool to exclude benign lesions.测定乳腺病变中的胆碱浓度:定量多体素质子磁共振波谱成像作为一种有前途的无创评估工具,可排除良性病变。
Radiology. 2011 Jun;259(3):695-703. doi: 10.1148/radiol.11101855. Epub 2011 Apr 1.
6
In vivo proton magnetic resonance spectroscopy of breast lesions: an update.乳腺病变的体内质子磁共振波谱分析:最新进展
Breast Cancer Res Treat. 2007 Sep;104(3):249-55. doi: 10.1007/s10549-006-9412-8. Epub 2006 Oct 19.
7
Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.利用体内质子磁共振波谱纵向监测恶性肌肉骨骼肿瘤的化疗效果:初步经验
J Comput Assist Tomogr. 2008 Nov-Dec;32(6):987-94. doi: 10.1097/RCT.0b013e31815b9ce9.
8
In vivo proton MR spectroscopy of the breast using the total choline peak integral as a marker of malignancy.利用总胆碱峰积分作为恶性肿瘤标志物的乳腺活体质子磁共振波谱分析。
AJR Am J Roentgenol. 2009 Jun;192(6):1608-17. doi: 10.2214/AJR.07.3521.
9
Quantitative multivoxel proton chemical shift imaging of the breast.乳腺的定量多体素质子化学位移成像。
Magn Reson Imaging. 2010 Apr;28(3):314-9. doi: 10.1016/j.mri.2009.11.004. Epub 2010 Jan 13.
10
Effect of contrast agent on the results of in vivo ¹H MRS of breast tumors - is it clinically significant?对比剂对乳腺肿瘤活体 ¹H MRS 结果的影响——是否具有临床意义?
NMR Biomed. 2012 Jan;25(1):67-74. doi: 10.1002/nbm.1714. Epub 2011 May 9.

引用本文的文献

1
Deuterium MR spectroscopy: potential applications in oncology research.氘磁共振波谱:在肿瘤学研究中的潜在应用。
BJR Open. 2024 Aug 5;6(1):tzae019. doi: 10.1093/bjro/tzae019. eCollection 2024 Jan.
2
In vivo deuterium magnetic resonance imaging of xenografted tumors following systemic administration of deuterated water.氘代水全身给药后异种移植瘤的体内氘磁共振成像。
Sci Rep. 2023 Sep 7;13(1):14699. doi: 10.1038/s41598-023-41163-9.
3
Probing lipids relaxation times in breast cancer using magnetic resonance spectroscopic fingerprinting.
利用磁共振波谱指纹技术探测乳腺癌中脂质弛豫时间。
Eur Radiol. 2023 May;33(5):3744-3753. doi: 10.1007/s00330-023-09560-w. Epub 2023 Mar 28.
4
Correlated MR spectroscopic imaging of breast cancer to investigate metabolites and lipids: acceleration and compressed sensing reconstruction.乳腺癌的相关磁共振波谱成像以研究代谢物和脂质:加速与压缩感知重建
BJR Open. 2022 Oct 12;4(1):20220009. doi: 10.1259/bjro.20220009. eCollection 2022.
5
Magnetic Resonance Imaging (MRI) and MR Spectroscopic Methods in Understanding Breast Cancer Biology and Metabolism.磁共振成像(MRI)及磁共振波谱方法在理解乳腺癌生物学与代谢方面的应用
Metabolites. 2022 Mar 27;12(4):295. doi: 10.3390/metabo12040295.
6
Multiparametric Magnetic Resonance Imaging in Evaluation of Benign and Malignant Breast Masses with Pathological Correlation.多参数磁共振成像在评估乳腺良恶性肿块中的应用及其与病理的相关性
Cureus. 2022 Feb 17;14(2):e22348. doi: 10.7759/cureus.22348. eCollection 2022 Feb.
7
Fat Composition Measured by Proton Spectroscopy: A Breast Cancer Tumor Marker?通过质子光谱法测量的脂肪成分:一种乳腺癌肿瘤标志物?
Diagnostics (Basel). 2021 Mar 21;11(3):564. doi: 10.3390/diagnostics11030564.
8
In vivo MR spectroscopy for breast cancer diagnosis.用于乳腺癌诊断的活体磁共振波谱分析
BJR Open. 2019 Jul 2;1(1):20180040. doi: 10.1259/bjro.20180040. eCollection 2019.
9
Clinical relevance of total choline (tCho) quantification in suspicious lesions on multiparametric breast MRI.多参数乳腺 MRI 可疑病变中总胆碱(tCho)定量的临床相关性。
Eur Radiol. 2020 Jun;30(6):3371-3382. doi: 10.1007/s00330-020-06678-z. Epub 2020 Feb 17.
10
Proton MR spectroscopy in the breast: Technical innovations and clinical applications.质子磁共振波谱在乳腺中的应用:技术创新与临床应用。
J Magn Reson Imaging. 2019 Oct;50(4):1033-1046. doi: 10.1002/jmri.26700. Epub 2019 Mar 7.